tiprankstipranks
pc:qua3k

Qualigen Therapeutics

Qualigen Therapeutics, soon to be rebranded as CXC10, is transitioning its focus to cryptocurrency and Web3-related business activities. The company will concentrate on developing C10 value anchor products, including treasury and index services, a DeAI Agent for trading optimization, and ecosystem tokens, with plans for a potential stablecoin.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$41M
Total Amount Raised$41M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$41M
Latest Funding Amount$41M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 22, 2025
Investment
$41.00M

Investors

Investor Name
Funding Round
Investment
Investment

Related News and Analysis